High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$898K
$898,840
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CDNA |
CareDx, Inc.
|
Director
Other
|
2026-03-31 | $88,648x3 | M | Form 4 |
|
CDNA
S
CareDx, Inc.
Novack Jeffrey Adam
• Officer • Secretary and General Counsel
10b5-1 Sell
2026-02-03
$91,286
|
||||||
| CDNA |
CareDx, Inc.
|
Officer • Secretary and General Counsel
10b5-1 Sell
|
2026-02-03 | $91,286 | S | Form 4 |
| CDNA |
CareDx, Inc.
|
CEO
10b5-1 Sell
|
2026-01-22 | $408,023 | S | Form 4 |
| CDNA |
CareDx, Inc.
|
CEO
10b5-1 Sell
|
2026-01-21 | $4,200 | S | Form 4 |
| CDNA |
CareDx, Inc.
|
CEO
10b5-1 Sell
|
2026-01-15 | $213,804 | S | Form 4 |
|
CDNA
S
CareDx, Inc.
Novack Jeffrey Adam
• Officer • Secretary and General Counsel
10b5-1 Sell
2025-12-04
$139,804x2
|
||||||
| CDNA |
CareDx, Inc.
|
Officer • Secretary and General Counsel
10b5-1 Sell
|
2025-12-04 | $139,804x2 | S | Form 4 |
|
CDNA
S
CareDx, Inc.
Novack Jeffrey Adam
• Officer • Secretary and General Counsel
10b5-1 Sell
2025-11-07
$41,723
|
||||||
| CDNA |
CareDx, Inc.
|
Officer • Secretary and General Counsel
10b5-1 Sell
|
2025-11-07 | $41,723 | S | Form 4 |